Hydroxyapatite nanoparticles modified by branched polyethylenimine are effective non-viral vectors for siRNA transfection of hepatoma cells in vitro

International Journal of Oncology
Xiao-Lin XuGao-Peng Li

Abstract

Small interfering RNA (siRNA) technology is a powerful tool in biomedical research and holds great potential for RNA interference-based therapies for HIV, hepatitis and cancer. However, the absence of a safe and efficient method for the delivery of siRNA has become a bottleneck for their development. Nanocrystallized hydroxyapatite (nHAP) appears to be an optimal candidate non-viral gene vector for several reasons, including its good biocompatibility and ease of production, however, nHAP microemulsions cannot remain monodispersed for long periods of time. Due to their high surface energy, nHAP particles gradually aggregate into large ones that are difficult for the cell to take up. To overcome this we modified nHAP with polyethylenimine (PEI) to generate a compound (MnHAP) with a tight size-distribution of <200 nm. The positive surface potential of MnHAP inhibited particle aggregation and thus made it easier to conjugate more siRNA. The transfection efficiency of MnHAP/fluorescent FAM-labeled siRNA complex was tested using flow cytometry, and the transfected cells were observed using fluorescence microscopy. The cytotoxicity of MnHAP/siRNA complexes to the human liver cancer cell line BEL-7402 was assessed in vitro by a formaza...Continue Reading

References

Feb 1, 1984·Analytical Biochemistry·M J Gorbunoff, S N Timasheff
Jul 9, 1999·Journal of Biomedical Materials Research·W T GodbeyA G Mikos
Nov 7, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·A von HarpeT Kissel
Sep 3, 2002·Advanced Drug Delivery Reviews·Irène BriggerPatrick Couvreur
Sep 13, 2003·World Journal of Gastroenterology : WJG·Zhi-Su LiuZhong-Li Ai
Jan 8, 2004·The Laryngoscope·John F Kveton, Daniel H Coelho
Mar 17, 2004·Biomaterials·T MatsumotoJ Takahashi
Sep 7, 2004·Journal of Materials Science. Materials in Medicine·H AokiM Niwa
Jan 11, 2005·Current Gene Therapy·Youngsuk YiKwan Hee Lee
Jun 9, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·U LungwitzA Göpferich
Feb 14, 2006·Biomaterials·Viktoriya V SokolovaMatthias Epple
Oct 24, 2006·Seminars in Cutaneous Medicine and Surgery·Alexander BerlinDavid J Goldberg
Mar 3, 2007·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Yantao ZhaoZhixuan Xu
Dec 7, 2007·The Journal of Clinical Investigation·Saghir Akhtar, Ibrahim F Benter
Aug 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Stephanie E A GrattonJoseph M DeSimone
Oct 5, 2010·Plastic and Reconstructive Surgery·Ahmed M AfifiJames E Zins
Nov 10, 2010·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Vuk Uskoković, Dragan P Uskoković
Feb 22, 2012·Liver International : Official Journal of the International Association for the Study of the Liver·Gaopeng LiBaoming Luo

❮ Previous
Next ❯

Related Concepts

Related Feeds

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.